Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression
Sponsor: Assaf-Harofeh Medical Center
Summary
The study evaluates the effect of HBOT on depression in patients suffering from persistent symptoms of post stroke depression (PSD) in an double blind sham control study.
Official title: Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression: A Prospective, Randomized, Double Blind Study
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
142
Start Date
2023-11-08
Completion Date
2030-12-01
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
hyperbaric oxygen therapy
The HBOT protocol consists of 60 daily sessions, five times per week, each session lasting 90 minutes. Investigational product: Multiplace hyperbaric oxygen chamber (Haux, Germany) located at the Sagol Center for Hyperbaric Medicine and Research, Shamir (Assaf-Harofeh) Medical Center, Israel.
Locations (1)
The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh)
Zrifin, Israel